Mezzanine Management sells Optimapharm to Rohatyn Group
Mezzanine Management has sold Croatian contract research organisation Optimapharm to asset management firm The Rohatyn Group (TRG).
More on CEE
Horizon backs Makeup Group
GP is investing from Emerging Europe Growth Fund III, which held a final close in January 2019 on €200m
Spectrum Equity IX hits $1.5bn hard-cap
Fund targets investments in internet-enabled software and information service companies
Unquote Private Equity Podcast: Back for secondaries
When activity begins again, will LPs be willing to take a pricing hit? And where will buyer and seller expectations meet?
Aquiline Capital closes fourth fund on $2bn
Fund invests in North American and European businesses operating across the financial services sector
Latest News
Plastic alternative producer Lactips raises €13m
Company has raised €20m so far over two funding rounds
Ping An Global leads €32m funding round for PlusDental
HV Holtzbrinck and Lakestar also participate in the round for the dental technology startup
IK closes ninth-generation fund on €2.85bn
IK VIII held a final close in November 2016 with €1.85bn and was 87% deployed as of December 2019
ArchiMed's Bomi bolts on Logifarma
With the GP's support, Bomi intends to pursue an intensive buy-and-build strategy